805. Meet-the-Professor
Session: Meet-the-Professor Session: Preventing Varicella-Zoster Virus Infections: A Fresh Look at Zoster and Varicella Vaccines in Clinical Practice
Saturday, October 22, 2011: 7:00 AM
Room: 156ABC

Michael N. Oxman, MD, FIDSA, San Diego VA Medical Center, San Diego, CA; University of California, San Diego, CA

Dr. Oxman is a Professor of Medicine and Pathology at the University of California, San Diego and a Staff Physician in the Infectious Diseases Section at the Veterans Administration Medical Center in San Diego. He is National Chairman of VA Cooperative Study #403: The Shingles Prevention Study. Dr. Oxman received his bachelorís degree from Harvard University in 1958 and his medical degree from Harvard Medical School in 1963. He served as an intern and resident on the Harvard Medical Service at the Boston City Hospital with Dr. Maxwell Finland; as a Staff Associate at the National Institute of Allergy and Infectious Diseases, National Institutes of Health with Dr. Wallace P. Rowe; and as a Research Fellow at Harvard Medical School with Dr. John F. Enders. He was a fellow and faculty member in the Childrens Hospital-Beth Israel Hospital Infectious Diseases Training Program; an Associate Professor of Microbiology and Molecular Genetics at Harvard Medical School; Director of the Clinical Virology Laboratory at Boston Childrens Hospital; and the recipient of an American Cancer Society Faculty Research Award. In 1976 he moved to the University of California, San Diego as Professor of Medicine and Pathology and Chief of the Infectious Diseases Section at the San Diego VA Medical Center. Dr. Oxman's major research interests have been the mechanism of action of Interferon, the control of SV40 and Adenovirus-SV40 hybrid virus gene expression, and the pathogenesis, diagnosis, treatment and prevention of viral diseases, especially diseases caused by members of the Herpesvirus family. He has played a significant role in training and mentoring physician-scientists at Harvard and the University of California, and in the use of double blind placebo-controlled clinical trials to evaluate the treatment of herpes simplex and varicella-zoster virus infections. He has authored more than 150 book chapters and articles in peer-reviewed scientific journals, and is the recipient of the 2005 VZV Research Foundation Lifetime Achievement Award, the 2005 Harold L. Stewart Lectureship at the Uniformed Services University of the Health Sciences, and the 2009 Stephen E. Straus Memorial Lectureship in Infectious Diseases at the National Institutes of Health. Dr. Oxman has served as a member of a number of advisory and editorial boards, including the NIAID Task Force on Virology; the NIH Experimental Virology Study Section; the Armed Forces Epidemiological Board; the Advisory Committee of the NIAID Collaborative Antiviral Study Group; the Science Board of the Biomedical Research Centre, University of British Columbia; the Microbiology Test Committee of the National Board of Medical Examiners; the Scientific Advisory Board of the Varicella-Zoster Virus (VZV) Research Foundation; the Defense Health Board; and editorial-advisory boards of the Journal of Interferon Research, Archives of Virology, Experientia, and Bailliere's Clinical Infectious Diseases. He is currently a Fellow of the Infectious Diseases Society of America and a member of the American Society for Virology, the American Society for Microbiology, the Society for General Microbiology, and the American Society for Clinical Investigation.

Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.